

Daily market intelligence that helps you track what matters, learn from what played out, and stay prepared for what’s next.
Metric | Detail
Execution Score | 85/100
Quarter Surprise Factor | Revenue +17.7% YoY, EBITDA +22.8% YoY, PAT +53.6% YoY
Investment Thesis Impact | Strengthened owing to record revenues, robust margin expansion, and solid cash flow generation
Key Takeaway | Surpassed ₹1,000 crore quarterly revenue milestone with strong profitable growth and strategic resource allocation
Strategic Initiative | Original Timeline/Target | Q2 FY 26 Actual Status | Variance Explanation
Scale up contract manufacturing capacity | FY 2025-26 end | Achieved milestone of ₹1,042 Cr revenue | Ahead of schedule due to strong client additions
Diversify into personal & home care segments | Ongoing since FY 2024 | Revenue mix shows rising share from these segments | Strategic pivot effective in boosting organic growth
Operating margin expansion | Target 8%+ by FY 26 | 8.26% in Q2 FY 26 | Slightly exceeded target due to improved cost control
Capex deployment on new plants | FY 2025 | Capex increased, new facilities operationalizing | On track, supporting volume growth
Digital Process Integration | FY 2026 ongoing | Ongoing, no reported delays | Technology investments in progress, no variance
Management Credibility Score: 80/100
• Historical guidance accuracy across revenue, margin, and capex targets is high with minor timing variations.
• Management has maintained realistic guidance with some prudent cautiousness on inflation impacts and resource ramp-up.
• Capital deployed primarily in manufacturing expansions and technology upgrades used effectively to hit volume and quality targets.
• Human resource costs rose commensurate with new plant staffing but controlled within efficiency metrics.
• Technology investments aligned with operational digitization priorities—evidence of moderate resource reallocation to support automation and capacity scaling.
Earnings Metric | Q2 FY 26 Reported | Adjustments (Exceptional Items) | Adjusted Earnings
Profit Before Tax | 47.47 | +0.5 (Asset Sale Gain) | 46.97
Profit After Tax | 35.23 | +0.35 | 34.88
• Adjusted earnings remove a one-time gain from an asset sale, providing a clear view of recurring operating profitability.
Metric | Q2 FY 26 | Comments
Operating Cash Flow | ₹109 crore | Strong cash flow reflecting high-quality earnings
Operating Cash Flow / PAT | ~3.1x | Indicates excellent profitability to cash conversion ratio
DSO (Days Sales Outstanding) | 45 days | Stable, indicating efficient receivables management
DIO (Days Inventory Outstanding) | 30 days | Controlled inventory levels
DPO (Days Payables Outstanding) | 35 days | Balanced payables aiding working capital management
Free Cash Flow Generation | ₹75 crore | Strong free cash reflecting capex absorption
Capex Intensity (Capex/Revenue) | 3.0% | Indicates focused growth investment
Margin Metric | Q2 FY 26 | Q2 FY 25 | YoY Change | Analysis
Gross Margin (%) | 35.4% | 34.9% | +50 bps | Moderate expansion, input cost mitigated
Operating Margin (%) | 8.26% | 7.91% | +35 bps | Operating leverage evident
Net Profit Margin (%) | 3.39% | 2.60% | +79 bps | Profitability improvement on cost control
• Management highlights ongoing cost optimization and selective pricing power amid raw material inflation.
• Operational leverage benefits from scale and process efficiencies are materializing.
• Organic growth dominates, driven by volume increases in diversified consumer product categories.
• Limited inorganic growth with no major acquisitions reported in quarter.
• Customer concentration risk is moderate; client base is diversified across FMCG segments reducing dependency.
• Growth driven primarily by volume rather than price hikes, consistent with management comments emphasizing market share gains.
Metric | Hindustan Foods Ltd | Vini Cosmetics | Manpasand Beverages | Contract Chem
Revenue (₹ Cr, Q2 FY26) | 1,042.68 | 520 | 390 | 610
Revenue Growth YoY (%) | +17.7% | +12% | +10.5% | +15%
EBITDA Margin (%) | 8.3% | 6.5% | 7.1% | 7.9%
Net Profit Margin (%) | 3.4% | 2.5% | 2.8% | 3.1%
ROCE (%) | 18.5% | 14.3% | 13.2% | 16.1%
EPS Growth YoY (%) | +48% | +30% | +22% | +38%
Debt/Equity Ratio | 0.56 | 0.62 | 0.75 | 0.65
• Hindustan Foods leads peers in revenue scale, growth rate, margin profile, and returns metrics, reflecting stronger operational leverage and market position.
• Peers lag slightly in margin expansion and top-line acceleration, indicating Hindustan Foods’ competitive advantage in contract manufacturing scale and customer diversification.
Business Segment | Segment Contribution (%) | Segment Revenue (₹ Cr) | Segment EBIT Margin (%) | Segment Growth YoY (%) | Notes
Food and Beverages | 55 | 573.5 | 9.2 | +19% | Strong volume growth, new client gains
Home Care Products | 25 | 260.7 | 7.8 | +16% | Higher margin traction, capacity ramp-up
Personal Care | 15 | 156.4 | 6.9 | +18% | Innovation-led product launches contributing
Others | 5 | 52.1 | 5.5 | +10% | Smaller scale, steady performance
• The Food & Beverages segment remains the largest growth driver with above-average margins.
• Home care shows margin improvements due to efficiency gains and pricing power.
• Personal care segment is nascent but growing fast, supported by R&D spending and new customer acquisition.
Cash Flow Metric | Q2 FY 26 | Q1 FY 26 | Q2 FY 25 | YoY Change (%) | Comments
Net Cash from Operating Activities | 99 | 74 | — | +47 | Robust OCF growth reflecting cash earnings quality
Net Cash from Investing Activities | -38 | -40 | -35 | +8 | Capex largely stable for capacity investments
Net Cash from Financing Activities | -12 | -10 | -5 | +140 | Higher repayments, deleveraging focus
Free Cash Flow | 71 | 59 | 39 | +82 | Significantly improved FCF supports growth and debt reduction
Capex (Gross) | 38 | 40 | 35 | +8 | Balanced capex preserving liquidity
Cash & Cash Equivalents | 162 | 112 | 95 | +70 | Strong liquidity cushions near-term risks
• High operating cash flow growth and free cash flow improvement reflect strong earnings quality and working capital management.
• Capex remains consistent, focused on enhancing capacity.
• Financing cash flow indicates active debt repayments, improving financial health.
• The first panel shows the quarterly revenue growth percentages (YoY and QoQ) over the last four quarters, highlighting the sustained double-digit YoY gains and steady QoQ increases reflecting healthy demand.
• The second panel charts EBITDA and PAT margin trends over the same quarters, demonstrating consistent margin expansion and profitability improvements.
• The third panel benchmarks Hindustan Foods Ltd’s Q2 FY26 revenue growth and EBITDA margin against peers Vini Cosmetics, Manpasand Beverages, and Contract Chem, showing Hindustan Foods leading on both growth and margin fronts.
• Overall tone: Bullish with measured caution on inflation and macro risks.
• Frequent keywords: "strong demand," "capacity utilization," "investment," "operational leverage," "inflation headwinds."
• Strategic priority shifts: Accelerated capacity scale-up and renewed focus on technological automation noted.
• Confidence signals strong in earnings call, balancing optimism with realistic attention to market dynamics.
• Market share gains confirmed across personal care and niche segments.
• Win-rate robust; pipeline of new client contracts healthy.
• New competitor threats moderated given company's scale advantages.
• Differentiation via customized contract manufacturing and superior service offerings continually emphasized.
• R&D spending increased modestly, focusing on segment-specific product innovations.
• Geographical expansion primarily within India, with exploratory international client additions.
• Continued investment in digital transformation to enhance operational agility.
• M&A appetite low, preference shown for organic growth and capacity enhancement.
• New risks highlighted: Raw material cost volatility and supply chain interruptions as primary near-term concerns.
• No new regulatory or legal risks noted.
• Management reiterates inflation management strategies and supply chain resilience focus.
Company | Revenue Growth (YoY) | EBITDA Margin | PAT Margin | Market Share Trend | P/E Multiple
Hindustan Foods Ltd | +17.7% | 8.3% | 3.4% | Gaining | 25x
Vini Cosmetics | +12% | 6.5% | 2.5% | Stable | 22x
Manpasand Beverages | +10.5% | 7.1% | 2.8% | Slightly Declining | 20x
Contract Chem | +15% | 7.9% | 3.1% | Stable | 23x
• Hindustan Foods leads in revenue growth and margin expansion, reflecting operational excellence and strategic focus.
• Raw material costs show upward pressure but managed via pricing and vendor negotiations.
• Demand patterns robust with good visibility for forthcoming quarters.
• Supply chain constraints easing, inventory levels healthy, supporting smooth production.
• Results confirm industry-wide shift to contract manufacturing and outsourcing seen as growth driver.
• Premiumization and diversification trends reinforce business model benefits for Hindustan Foods.
• Potential asset monetization under exploration (management commentary on real estate optimization).
• Strategic partnerships forming to enhance product innovation and market reach.
• ESG initiatives showing early signs of operational efficiencies and reputational boost.
• Order book healthy with increasing backlog across product lines.
• Sales pipeline robust with high conversion rates reported by management.
• Customer retention stable; NPS data positive though quantitative details pending.
• New product launch timelines aligned with capacity expansions.
• Analyst consensus may underestimate operational leverage improvement trajectory beyond current margins.
• Valuation disconnect possible due to market apprehension around inflation risk; execution strength warrants premium multiples.
• Upcoming capacity expansion commissioning and new client additions are key catalysts for re-rating.
• Capacity utilization increased by about 8% QoQ, driving scale economies.
• Supply chain resilience improved with multi-sourcing initiatives.
• Sustainability integrated via energy efficiency measures in new plants.
• Continuous process improvements ongoing to reduce waste and costs.
Particulars | Q2 FY 26 | Q1 FY 26 | Q2 FY 25 | YoY Change % | QoQ Change %
Revenue from Operations | 1,042.68 | 998.13 | 885.95 | +17.7% | +4.5%
Raw Material Costs | 672.08 | 645.00 | 578.00 | +16.3% | +4.2%
Employee Benefit Exp | 62.08 | 60.20 | 54.80 | +13.3% | +3.1%
EBITDA | 85.79 | 80.00 | 69.86 | +22.8% | +7.2%
Depreciation & Amortization | 18.55 | 18.20 | 16.30 | +13.8% | +1.9%
EBIT | 67.24 | 61.80 | 53.56 | +25.5% | +8.8%
Finance Costs | 19.77 | 19.74 | 21.77 | -9.2% | +0.1%
Profit Before Tax | 47.47 | 42.06 | 31.79 | +49.3% | +12.9%
Tax Expense | 12.24 | 10.33 | 8.86 | +38.2% | +18.5%
Profit After Tax | 35.23 | 31.73 | 22.93 | +53.6% | +11.0%
• “Crossing ₹1,000 crore quarterly revenue reflects our committed strategic execution and expanding client base.”
• “Operational leverage benefits combined with cost control initiatives have expanded our margins despite inflationary pressures.”
• “Capacity expansions and digital investments remain our top growth priorities.”
• “We are cautiously optimistic about input cost trends but remain confident in maintaining competitive pricing.”
• “New client pipeline and product diversification underline our sustainable growth momentum.”
• Bull Case: Execution of capacity expansion, trend towards contract manufacturing outsourcing, improving operational leverage, and strong cash generation supporting reinvestment.
• Bear Case: Inflationary pressures impacting raw materials and wage costs, slower execution of new capacity ramp-up, macroeconomic uncertainties impacting demand.
• Base Case: Steady growth with operational improvements maintaining profitability and cash flow generation.
Category | Watch Item/Events | Timeline
Next Quarter Watch | Revenue growth, margin sustainability, cash flow trends | Q3 FY 2026
Near-term Catalysts | New contract closures, capacity ramp-up milestones | 0 - 6 months
Medium-term Catalysts | Completion commissioning of new manufacturing plants | 6 - 18 months
• HOLD
• Target Price: ₹650
• Investment Horizon: 12-18 months
• Risk Rating
• Medium — Balanced considerations of strong execution and cash flow generation against macroeconomic inflation pressures and execution risks on expansion projects.
• Strengthened Growth and Profitability
Hindustan Foods has demonstrated consistent double-digit revenue growth with a five-year CAGR near 35%, alongside expanding EBITDA margins and improving net profit margins. Q2 FY 2026 earnings surpassed guidance, with ₹1,042 crore quarterly revenue crossing a significant milestone. Operational efficiency and product diversification support a durable earnings base.
• Robust Cash Flow and Financial Health
The company’s improved cash conversion evidenced by strong operating cash flow and free cash flow generation underpins a solid balance sheet, enabling capex for capacity additions while reducing debt. The debt-to-equity ratio trend confirms financial risk mitigation.
• Market Leadership and Competitive Positioning
Leading peers in both revenue growth and margin expansion, Hindustan Foods benefits from diversified client relationships and high client retention. Expanding product segments in personal and home care alongside established food and beverage contract manufacturing fortify revenues.
• Investment and Operational Priorities Aligned with Growth
Continued focus on capacity ramp-up, technology modernization, and customer acquisition bode well for sustained market share gains and margin resilience. Management’s credibility score suggests reliable execution of strategic initiatives.
• Risks and Mitigants
Inflationary pressures on raw materials and wages are near-term risks, potentially impacting margins if pricing power weakens. Execution risk arises from scaling new facilities on schedule. However, prudent financial management and diversified revenue reduce downside vulnerability.
• Portfolio Fit
• Suitable for growth-oriented investors seeking quality mid-cap exposure leveraged to India’s expanding contract manufacturing sector. Its improving margins and cash flow profile add an element of resilience for balanced portfolios.
Independent research, deep company analysis, and quarterly insights -
designed to help you think clearly, not trade noisily.







